Skip to content

Clinical trials

Phase 3 Squamous Cell Carcinoma of Head and Neck trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 3 Country / region: United Kingdom Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20071
20102
20121
20142
20151
20161
20173
20204
20211
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Terminated4
Active, not recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
European Organisation for Research and Treatment of Cancer - EORTC3
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Merus B.V.2
AVEO Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
CEL-SCI Corporation1
Cancer Research UK1
Corbus Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck29
Head and Neck Neoplasms14
Carcinoma, Squamous Cell3
Laryngeal Diseases2
Neoplasm Metastasis2
Recurrence2
Carcinoma1
Oropharyngeal Neoplasms1
Radiation Injuries1
Salivary Gland Neoplasms1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.